310 related articles for article (PubMed ID: 23725175)
1. Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer.
Hu LA; Fu Y; Zhang DN; Zhang J
Asian Pac J Cancer Prev; 2013; 14(4):2563-6. PubMed ID: 23725175
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
3. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
[TBL] [Abstract][Full Text] [Related]
4. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
6. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Hao K; Yu L; Zhang X
Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.
Gu X; Tian T; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
Tumour Biol; 2015 Apr; 36(4):2651-6. PubMed ID: 25480413
[TBL] [Abstract][Full Text] [Related]
9. Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients.
Fei ZH; Yao CY; Yang XL; Huang XE; Ma SL
Asian Pac J Cancer Prev; 2013; 14(9):5293-9. PubMed ID: 24175816
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
12. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Yu LK; Zhang X
Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group.
Tanriverdi O; Avci N; Oktay E; Kalemci S; Pilanci KN; Cokmert S; Menekse S; Kocar M; Sen CA; Akman T; Ordu C; Goksel G; Meydan N; Barutca S
Asian Pac J Cancer Prev; 2015; 16(14):5971-6. PubMed ID: 26320482
[TBL] [Abstract][Full Text] [Related]
14. Serum chemokine network correlates with chemotherapy in non-small cell lung cancer.
Yang D; Zhou J; Zeng T; Yang Z; Wang X; Hu J; Song Y; Chen L; Peer D; Wang X; Bai C
Cancer Lett; 2015 Aug; 365(1):57-67. PubMed ID: 25976768
[TBL] [Abstract][Full Text] [Related]
15. Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.
Oven Ustaalioglu B; Bilici A; Ercan S; Orcun A; Seker M; Ozkan A; Ustaalioglu R; Gumus M
Clin Transl Oncol; 2012 May; 14(5):356-61. PubMed ID: 22551541
[TBL] [Abstract][Full Text] [Related]
16. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer.
Xu Z; Qi X; Zhang X; Yu L
Tumour Biol; 2014 May; 35(5):5007-11. PubMed ID: 24510346
[TBL] [Abstract][Full Text] [Related]
18. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
Naumnik W; Naumnik B; Niklińska W; Ossolińska M; Chyczewska E
Adv Exp Med Biol; 2016; 952():41-49. PubMed ID: 27573644
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
